Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).

Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Choroidal Thickness

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Regensburg

Regensburg, Bavaria, 93053, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with initial diagnosis of CSCR and no treatment so far

Exclusion criteria

Therapy (drugs/laser) due to CSCR

Sponsors and collaborators

Lead sponsor

University Hospital Regensburg

Other

Registry information

Official study title

Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2012
First posted: Jun 4, 2012
Registry last updated: Jun 4, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed